Landscapes / Companies
Byondis B.V. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 1
Next date
None yet
Drugs
2
in active trials · 6 in all
Trials
3 active
10 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1 | — | |||
| Also tested for | Lymphoma, Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Relapsed / Refractory AML, Relapsed / Refractory MDS | ||||
| Open drug page | |||||
About
- No active trial
- BYON3521, BYON5667, SYD1875, trastuzumab duocarmazine
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021